A clinical trial can only be as strong as the population it’s actively serving and reaching. In addition, the participant population must match the population of those who require treatment. However, a lot of research teams still struggle to retain participants and improve access in clinical trials. While there may be a lot of factors involved in this challenge, location substantially affects the ability of a person to participate or not.
Moreover, the industry is witnessing a challenge in recruiting enough clinicians to participate in recruitment efforts. This is due to the low incentive ratio and high cost.
Here, our clinical EDC expert for rapid study development highlights what the industry can do to improve patient centricity and research access!
Designing an adaptive clinical trial with Clinical Data Management Software
When we move toward a decentralized model, we’re moving away from limiting trials with labels. Here’s the key to success in a decentralized landscape: design your trial to be adaptive and deployed in multiple ways based on therapeutic area, technology, participant preference, and more. In this approach, providers and patients are in the middle, and various aspects going into a clinical trial surround them, including:
- Sponsors
- Telemedicine
- Care providers
- Site
- Home
Bringing all of these components together enables the patient to participate how they wish to and in ways that work best for their lifestyles. By enabling the most efficient modality for that particular intervention, everyone can participate, which in turn strengthens representation across the industry.
Addressing common challenges
The coronavirus pandemic has given the research industry the infrastructure and workflows to tackle these challenges and change how research is performed through DCTs (decentralized clinical trials).
DCTs are defined as a non-traditional clinical trial model, DCTs use processes and technology to create options for participation beyond an exclusive physical presence at research sites. A decentralized model encompasses remote, virtual, agile, and hybrid study designs.
To solve the industry’s biggest challenges and reap many benefits, a shift to a decentralized model is important. From a participation standpoint, we can eliminate the requirement to conduct every visit at a physical research site while allowing patients from various parts of the world or country to participate. By doing so, we enable ourselves to decrease trial costs, increase representation, and condense the overall trial timeline.
In addition, if we expand participation beyond just clinicians at sites, we can include more clinicians at various organization types and locations. This will also help in broadening patient access by introducing clinical research to organizations normally without the alternative of offering a trial as a care option for their patients.
ClinicalPURSUIT’s clinical data management and EDC offers simple yet advanced clinical data management
Whether you’re a clinical data manager, a CRO or a study sponsor, ClinicalPURSUIT’s configurable dashboards deliver exactly the information you need.
Get in touch with us now for more information on our clinical data management EDC system!
